Saturday, March 25, 2023
News Media Empire
  • About Us
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Home
  • World News
  • Politics
  • Business & Economy
  • Money
  • Science & Tech
  • Opinion
  • Lifestyle
  • Health
  • Sports
  • Entertainment
  • Crypto
No Result
View All Result
  • Home
  • World News
  • Politics
  • Business & Economy
  • Money
  • Science & Tech
  • Opinion
  • Lifestyle
  • Health
  • Sports
  • Entertainment
  • Crypto
No Result
View All Result
News Media Empire
No Result
View All Result
Home Health

Treatments for post-vaccine blood clots show promise but no ‘slam dunk,’ Canadian doctors say | CBC News

June 9, 2021
in Health
0
Treatments for post-vaccine blood clots show promise but no 'slam dunk,' Canadian doctors say | CBC News
0
SHARES
Share on FacebookShare on TwitterShare on RedditShare on Whatsapp


Ever since health officials announced Canada’s first known case of rare, post-vaccination blood clots back in April, scientists have been racing to learn more about what causes the potentially deadly condition — and how to treat it.

Now, a team from McMaster University in Hamilton has published new research-backed recommendations calling on clinicians to use a combination of two treatments: anti-clotting drugs alongside high doses of an intravenous, antibody-based therapy.

The potential effectiveness was outlined in three case studies featuring some of the first Canadian patients who developed post-vaccine blood clots, which was published Wednesday in The New England Journal of Medicine.

The three patients between the ages of 63 and 72 were all given a dose of the AstraZeneca-Oxford COVID-19 vaccine, the paper states, and were later diagnosed with vaccine-induced immune thrombotic thrombocytopenia (VITT).

Two developed clotting in their legs, including one who later required amputation, and the third suffered from blocked arteries and veins inside their brain.

WATCH | Researcher explains IVIG treatment:

Ishac Nazy is one of the researchers behind a new paper focused on treatments for post-vaccine blood clots, and the scientific director of the McMaster Platelet Immunology Laboratory. Here, he explains how intravenous immunoglobulin, or IVIG, works to treat patients suffering from these rare, but potentially-deadly, clots. 0:43

“What we recognized early on is that all three patients were treated with anticoagulants [or anti-clotting medication] along with intravenous immunoglobulin, or IVIG,” said Ishac Nazy, one of the researchers behind the new report and the scientific director of the McMaster Platelet Immunology Laboratory.

IVIG is a treatment made up of antibodies that can be given intravenously, and it’s long been used to help treat autoimmune conditions.

The three patients who received the treatment all survived, the paper noted.

How does IVIG work?

So how — and why — does IVIG seem to work for patients with post-vaccine blood clots?

While there’s still more research needed into why the condition happens in the first place, the study team suspects that for certain people, getting vaccinated with a viral-vector shot like AstraZeneca leads to the development of antibodies that attack a particular blood protein, which activates platelets in the bloodstream and causes them to clump together. 

IVIG treatment seems to work by flooding the system with different antibodies, which “outcompete” the patient’s own supply to prevent the chain of events leading to blood clots, Nazy explained.

The McMaster Platelet Immunology Laboratory has over 30 years of research into immune mediated platelet disorders, and operates under the direction of Ishac Nazy, left, Dr. Donald Arnold, centre, and Dr. John Kelton, right. (Submitted by McMaster University)

The team believes the therapy slows down the blood-clotting process, giving anti-clotting drugs time to work.

“This is a multi-faceted approach to try to target the clotting event from different angles,” Nazy said.

Lab work by the team found blood samples from the three patients all showed a drop in platelet activation after the treatment.

Not a ‘perfect drug’

But outside experts on blood-clotting conditions who viewed an advance copy of the paper stressed it’s just a starting point.

While the three case studies are “encouraging,” they only provide anecdotal evidence in an area that warrants far more research, said Halifax-based hematologist Dr. Sudeep Shivakumar, the interim division head and service chief for hematology at Dalhousie University’s Faculty of Medicine.

“It’s not a slam dunk,” he added, “but it does give us ideas for future studies.”

So far, there have been at least five deaths and 28 cases of vaccine-induced immune thrombotic thrombocytopenia, or VITT, reported in Canada following the countrywide distribution of more than 2.8 million doses of the AstraZeneca-Oxford vaccine. (Jeff McIntosh/The Canadian Press)

Dr. Lana Castellucci, a thrombosis physician and researcher with the Ottawa Hospital Research Institute, agrees the findings are just a jumping-off point, but says the recommendations are in line with discussions among clinicians across Canada who are navigating how to treat VITT.

Ontario’s COVID-19 Science Advisory Table, for instance, suggested both anti-clotting drugs and IVIG in its list of VITT treatment options, which formed part of the group’s interim guidance for health-care professionals back in May.

“The potential to see this as ongoing diagnosis remains, and knowing we have treatment strategies that are effective is certainly helpful,” Castellucci said.

Nazy himself acknowledged IVIG is not a “perfect drug,” and doesn’t work for every patient — noting that one of his three wound up requiring a different treatment later on, though he too eventually improved.

There have also been concerns over access and supply levels of the plasma-based treatment in recent years.

National surveillance program set up

The McMaster lab team set up a national surveillance program for VITT earlier this year and physicians around the country began sharing their clinical data, patient samples and treatment plans and progress updates.

That helped the researchers confirm VITT cases before Canadian physicians had encountered the condition, and allowed them to gauge different treatment approaches.

Months later, there are still significant unanswered questions about the mechanism behind VITT, and why it strikes certain individuals in rare circumstances.

So far, there have been at least 28 cases reported in Canada and five deaths, following the countrywide distribution of more than 2.8 million doses of the AstraZeneca vaccine.

“Is there a particular group that’s at greater risk than others?” Castellucci questioned. “Is there an age group that’s at risk? A gender more at risk — females more than males, for example?”

Guidelines allowing Canadians the choice to switch between manufacturers for each shot, and several provinces halting the use of AstraZeneca for first doses, “takes away a lot of the uncertainty” faced by many Canadians, she added.

“We know the mRNA vaccines have not seen complications like this,” Castellucci said.



Source link

Get Free Advertise Coin
Previous Post

Dollarama sales climbed 13% in latest quarter despite COVID-19 restrictions

Next Post

GameStop names former Amazon exec as CEO, says it may sell shares

Related Posts

Bird flu’s momentum in Canada worries experts: ‘Potential to become a pandemic’ - National | Globalnews.ca
Health

Bird flu’s momentum in Canada worries experts: ‘Potential to become a pandemic’ – National | Globalnews.ca

March 25, 2023
Cosmetic brands may have to disclose fragrance ingredients — a welcome change for Canadians with allergies | CBC News
Health

Cosmetic brands may have to disclose fragrance ingredients — a welcome change for Canadians with allergies | CBC News

March 24, 2023
Ontario reaches funding deal with optometrists, seniors eye exam eligibility to change | CBC News
Health

Ontario reaches funding deal with optometrists, seniors eye exam eligibility to change | CBC News

March 24, 2023
Next Post
GameStop names former Amazon exec as CEO, says it may sell shares

GameStop names former Amazon exec as CEO, says it may sell shares

Who decided Ontario schools should stay closed? Doctors call on Ford to reconsider | CBC News

Who decided Ontario schools should stay closed? Doctors call on Ford to reconsider | CBC News

Canada still lacks national guidance for fully vaccinated Canadians as travel restrictions ease | CBC News

Canada still lacks national guidance for fully vaccinated Canadians as travel restrictions ease | CBC News

Discussion about this post

AdvertiseCoin ADCO Get Now Free
News Media Empire

Newsmediaempire is an online news source that provides the latest news and other information about everything that you must need to know. It publishes news related to various fields like world, business, sports, politics, tech, health, lifestyle, and other different exclusive stories.

Let's connect!

Categories

  • Business & Economy
  • Crypto
  • Entertainment
  • Health
  • Lifestyle
  • Money
  • Opinion
  • Politics
  • Science & Tech
  • Sports
  • World News

Recent News

  • TOSS REPORT | Windies win toss, bowl first in 11-overs a side first T20 | Sport March 25, 2023
  • Bitcoin To $1 Million: Ex-Coinbase CTO Assures Off Bet; But There’s A Catch March 25, 2023
  • Vladimir Putin's daughter rules young Russians aren't patriotic enough on social media March 25, 2023

Join Our Newsletter!

    • About Us
    • Contact
    • Privacy Policy
    • Terms & Conditions

    newsmediaempire.com © 2021 All rights reserved.

    No Result
    View All Result
    • About Us
    • Contact
    • Home 1
    • Home 2
    • Home 3
    • Privacy Policy
    • Random
    • Sample Page
    • Terms & Conditions

    newsmediaempire.com © 2021 All rights reserved.

    en English
    ar Arabicbg Bulgarianzh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish
    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.